Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Collinson PO, Gaze DC, Thokala P, et al. Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation (RATPAC CBE). Southampton (UK): NIHR Journals Library; 2013 Apr. (Health Technology Assessment, No. 17.15.)
Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation (RATPAC CBE).
Show details- ACS
acute coronary syndrome
- AM
adrenomedullin
- AMI
acute myocardial infarction
- ANP
atrial natriuretic peptide
- AUC
area under the curve
- AVP
arginine vasopressin
- BNP
B-type natriuretic peptide
- CK
creatine kinase
- CK-MB
creatine kinase MB isoenzyme
- CRP
C-reactive protein
- cTnI
cardiac troponin I
- cTnT
cardiac troponin T
- CTU
Clinical Trials Unit
- CV
coefficient of variation
- ECG
electrocardiogram
- ED
emergency department
- EDTA
ethylenediaminetetraacetic acid
- FABP
fatty acid-binding protein
- GDF15
growth differentiation factor 15
- GRACE
Global Registry of Acute Coronary Events
- H-FABP
heart-type fatty acid-binding protein
- HTA
Health Technology Assessment
- ICER
incremental cost-effectiveness ratio
- IL
interleukin
- IL-1
interleukin 1
- IL-1β
interleukin 1 beta
- IL-33
interleukin 33
- IL-6
interleukin 6
- IL-6R
interleukin-6 receptor
- IMA
ischaemia-modified albumin
- IQR
interquartile range
- MACE
major adverse cardiac event
- MMP
matrix metalloproteinase
- MPO
myeloperoxidase
- NICE
National Institute for Health and Care Excellence
- NSTEMI
non-ST-segment elevation myocardial infarction
- NTproBNP
N-terminal pro-B-type natriuretic peptide
- NYHA
New York Heart Association
- PAPP-A
pregnancy-associated plasma protein A
- QALY
quality-adjusted life-year
- RATPAC
Randomised Assessment of Treatment using Panel Assay of Cardiac markers
- RATPAC-CBE
Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation
- RCV
relative change value
- ROC
receiver operating characteristic
- sIL-6R
soluble interleukin-6 receptor
- STEMI
ST-segment elevation myocardial infarction
- TIMP
tissue inhibitor of metalloproteinase
- TnC
troponin C
- TnI
troponin I
- TnT
troponin T
- WHO
World Health Organization
All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices in which case the abbreviation is defined in the figure legend or at the end of the table.
- List of abbreviations - Randomised Assessment of Treatment using Panel Assay of ...List of abbreviations - Randomised Assessment of Treatment using Panel Assay of Cardiac markers – Contemporary Biomarker Evaluation (RATPAC CBE)
- Critical appraisal of company submissions - Immunosuppressive therapy for kidney...Critical appraisal of company submissions - Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model
- The HubBLe Trial: haemorrhoidal artery ligation (HAL) versus rubber band ligatio...The HubBLe Trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for symptomatic second- and third-degree haemorrhoids: a multicentre randomised controlled trial and health-economic evaluation
- Factors considered while rating the quality of the evidence - WHO Guidelines on ...Factors considered while rating the quality of the evidence - WHO Guidelines on the Management of Health Complications from Female Genital Mutilation
- Lapatinib and Trastuzumab in Combination with an Aromatase Inhibitor for the Fir...Lapatinib and Trastuzumab in Combination with an Aromatase Inhibitor for the First-Line Treatment of Metastatic Hormone Receptor-Positive Breast Cancer which Over-Expresses Human Epidermal Growth Factor 2 (HER2): A Systematic Review and Economic Analysis
Your browsing activity is empty.
Activity recording is turned off.
See more...